未使用降眼压药物的近视合并正常眼压性青光眼的临床病程及视野进展危险因素
该回顾性队列研究纳入97例未使用青光眼药物的近视合并正常眼压性青光眼患者,平均随访71.1±29.7个月,32眼出现视野进展。Kaplan-Meier生存曲线显示36个月和60个月进展率分别为10.3%和24.8%,年龄≤50岁及视盘倾斜方向<45度者累积进展概率更高,Cox模型显示年轻、视盘出血及更偏颞侧的视盘倾斜或视盘旁萎缩与进展相关。
要点
- 未用药近视合并正常眼压性青光眼3年视野进展率10.3%,5年24.8%。
- 年龄≤50岁者累积进展概率高于>50岁者(P=.001)。
- 视盘倾斜方向<45度者累积进展概率高于≥45度者(P=.002)。
核心结论
- 近视合并正常眼压性青光眼即使不使用青光眼药物,似乎也进展缓慢。
- 在未治疗的近视合并正常眼压性青光眼中,3年和5年随访时分别仅有10.3%和24.8%的患者出现视野进展。
- 为预测未治疗的近视合并正常眼压性青光眼的视野进展,似乎应考虑年龄和视盘形态。
研究设计与样本
- 回顾性队列研究,纳入97例未使用青光眼药物的近视合并正常眼压性青光眼患者,随访至少3年。
- 采用Kaplan-Meier生存分析和log-rank检验比较组间生存经验,采用Cox比例风险模型确定潜在危险因素与青光眼性进展之间的风险比(HR)。
主要发现
- 纳入的97例患者平均随访71.1±29.7个月,观察期间32眼出现进展。
- Kaplan-Meier生存曲线显示,近视合并正常眼压性青光眼36个月进展率为10.3%,60个月为24.8%。
- 按年龄和视盘倾斜方向分为2组后,年龄≤50岁者累积进展概率高于>50岁者(P=.001),视盘倾斜方向<45度者累积进展概率高于≥45度者(P=.002)。
- Cox比例风险模型显示,较年轻、存在视盘出血以及更偏颞侧的视盘倾斜或视盘旁萎缩与进展相关。
关键数值与推荐
- 36个月进展率为10.3%,60个月进展率为24.8%。
- 年龄≤50岁 vs >50岁:累积进展概率更高(P=.001)。
- 视盘倾斜方向<45度 vs ≥45度:累积进展概率更高(P=.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the natural clinical course and the risk factors of visual field (VF) progression in untreated normal-tension glaucoma (NTG) with myopia with a minimum 3-year follow-up. DESIGN: Retrospective cohort study. METHODS: Kaplan-Meier survival analysis and log-rank test were used to compare survival experiences between the groups. The hazard ratios (HRs) for the associations between potential risk factors and glaucomatous progression were determined using Cox proportional hazards model. RESULTS: The average follow-up period for the included 97 patients was 71.1 ± 29.7 months and 32 eyes showed progression during the observation period. In NTG with myopia, Kaplan-Meier survival curve showed progression cases in 10.3% at 36 months and 24.8% at 60 months. When age and disc tilt direction were classified into 2 groups, a higher cumulative probability of progression was observed in those aged ≤50 years than >50 years (P = .001) and in those with disc tilt direction <45 degrees than disc tilt direction ≥45 degrees (P = .002). In Cox proportional hazards model, younger age, presence of disc hemorrhage, and more temporally tilted disc or parapapillary atrophy were associated with progression. CONCLUSIONS: NTG with myopia seems to have a slow progression rate even without glaucoma medications. Only 10.3% and 24.8% of patients showed VF progression at 3 years and 5 years of follow-up in untreated NTG with myopia. To predict VF progression in untreated NTG with myopia, it seems that age and disc morphology should be considered.
引用
- Han JC, Han SH, Park DY, et al. Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications. Am J Ophthalmol. 2019. PMID: 31493404. doi:10.1016/j.ajo.2019.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。